CD8A and neoplasm: CD8+ TIL analysis revealed elevated proliferative capacity, and activation as well as the maintenance of the ability to identify tumor antigens specifically of tumor-specific DP T cells in patients (N=4/16) with evaluable tumor tissues, and all patients stayed disease-free (89).